Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Transition metals are vital but their metabolic dysregulation leads to toxicity.
• Glioblastoma is an aggressive brain tumor with limited treatment options.

Purpose of the Study:

• To investigate the mechanism of action of compound NSC319726 in glioblastoma cells.
• To explore the role of copper binding in NSC319726's anti-cancer effects.

Main Methods:

• Pharmacogenomic analysis of NSC319726 and its analogs.
• Cell-based assays to assess cell cycle arrest and oxidative stress.
• Hypoxia and hypoxia-inducible-factor-1α pathway modulation.

Main Results:

• NSC319726 binds copper, not zinc, to arrest glioblastoma cell growth at picomolar concentrations.
• Copper toxicity was modulated by hypoxia via a hypoxia-inducible-factor-1α-dependent pathway.
• Copper-bound NSC319726 induced reactive oxygen species and depleted deoxyribosyl purines, causing cell-cycle arrest.

Conclusions:

• NSC319726's anti-glioblastoma activity is mediated by copper binding and subsequent oxidative DNA damage.
• This copper-targeting mechanism presents a novel therapeutic strategy for glioblastoma.
• Metal-induced DNA damage is a potential consequence of xenobiotic exposure and copper dysregulation.